AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 75 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $862 | +24.6% | 756 | 0.0% | 0.00% | – |
| Q2 2023 | $692 | +63.2% | 756 | 0.0% | 0.00% | – |
| Q1 2023 | $424 | -2.8% | 756 | 0.0% | 0.00% | – |
| Q4 2022 | $436 | – | 756 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 756 | -16.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 900 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $2,000 | -33.3% | 900 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $3,000 | 0.0% | 900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | 0.0% | 900 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | +200.0% | 900 | +81.8% | 0.00% | +100.0% |
| Q4 2020 | $1,000 | -83.3% | 495 | 0.0% | 0.00% | -83.3% |
| Q2 2020 | $6,000 | +100.0% | 495 | -42.5% | 0.01% | +200.0% |
| Q3 2019 | $3,000 | -40.0% | 861 | -7.9% | 0.00% | -33.3% |
| Q2 2019 | $5,000 | -37.5% | 935 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $8,000 | 0.0% | 935 | -2.6% | 0.01% | +50.0% |
| Q3 2018 | $8,000 | – | 960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |